PRostate Olaparib Real World Evidence Study

Inclusion Criteria:

• Adult male patients (≥ 18 years old)

• With metastatic castration-resistant prostate cancer - Who have initiated olaparibwithin the last two months of study entry, or for whom the decision to be treatedwith olaparib has been made by their physician

• Who have been informed and are not opposed to this data collection

Exclusion Criteria:

• Patients opposed to the collection of their data

• Patients participating in a clinical trial with an investigational prostate cancertargeted drug within 30 days prior to Olaparib initiation